• LAST PRICE
    0.4050
  • TODAY'S CHANGE (%)
    Trending Down-0.0001 (-0.0247%)
  • Bid / Lots
    0.4000/ 31
  • Ask / Lots
    0.4200/ 1
  • Open / Previous Close
    0.4000 / 0.4051
  • Day Range
    Low 0.3853
    High 0.4051
  • 52 Week Range
    Low 0.3853
    High 1.5100
  • Volume
    343,409
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.4051
TimeVolumeAIM
09:32 ET68060.404
09:33 ET50000.4049
09:37 ET1200.4049
09:39 ET1000.4049
09:42 ET994130.4
09:44 ET1000.4039
09:50 ET1330.4038
10:02 ET3000.4045
10:04 ET1000.4045
10:13 ET81240.4046
10:26 ET11000.4049
10:33 ET13500.405
10:36 ET2000.405
10:42 ET1000.405
10:44 ET11310.4051
10:51 ET315690.3969
10:54 ET27400.4
10:56 ET2000.399
11:05 ET100000.4
11:18 ET1000.3952
11:20 ET10010.3904
11:23 ET1000.391804
11:36 ET99000.391
11:43 ET10000.4
11:50 ET44500.3954
11:52 ET1000.3942
11:57 ET435210.39
11:59 ET3000.39005
12:01 ET20000.39
12:06 ET32490.39005
12:08 ET4500.39
12:10 ET45560.39
12:12 ET3000.3854
12:14 ET18000.3853
12:15 ET38340.3854
12:26 ET10000.385601
12:30 ET26000.389899
12:39 ET35000.389
12:42 ET24860.3899
12:44 ET174000.3883
12:46 ET1800.3883
01:04 ET7000.3883
01:06 ET63900.388781
01:08 ET10000.3888
01:09 ET20000.3999
01:11 ET10000.3901
01:13 ET8000.399899
01:22 ET68880.3999
02:03 ET25020.3949
02:05 ET6350.3949
02:12 ET12520.395
02:23 ET14000.394
02:27 ET9370.3999
02:30 ET4000.3999
02:32 ET12680.390201
02:50 ET46310.3902
02:57 ET5000.391201
03:06 ET11330.4
03:28 ET10000.3915
03:30 ET55990.3934
03:32 ET1330.3933
03:37 ET3000.3934
03:39 ET1000.399999
03:42 ET1170.4
03:44 ET1000.3999
03:50 ET53500.399914
03:51 ET61000.3957
03:53 ET1000.3924
03:55 ET90450.3983
03:57 ET1200.404999
04:00 ET00.405
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAIM
AIM ImmunoTech Inc
19.5M
-0.9x
---
United StatesNRSN
Neurosense Therapeutics Ltd
19.6M
-2.7x
---
United StatesAIKI
Aikido Pharma Inc
19.7M
-0.9x
---
United StatesCDIO
Cardio Diagnostics Holdings Inc
19.2M
0.0x
---
United StatesNNVC
NanoViricides Inc
19.0M
-2.6x
---
United StatesRUBY
Rubius Therapeutics Inc
18.7M
-0.1x
---
As of 2022-11-30

Company Information

AIM ImmunoTech Inc. is an immuno-pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases and immune-deficiency disorders. The Company’s flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules, and Alferon N Injection (Interferon Alfa-N3). Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS) and is an experimental drug in the United States undergoing clinical development for the treatment of certain cancers and ME/CFS. Alferon N Injection is the registered trademark for its injectable formulation of natural alpha interferon. Alferon N Injection is a natural-source, multi-species alpha interferon approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

Contact Information

Headquarters
2117 SW Highway 484OCALA, FL, United States 34473-7949
Phone
352-448-7797
Fax
352-480-4620

Executives

Independent Chairman of the Board
William Mitchell
President, Chief Executive Officer, Executive Vice Chairman
Thomas Equels
Chief Financial Officer
Robert Dickey
Chief Operating Officer, Executive Director - Governmental Relations, General Counsel, Secretary
Peter Rodino
Chief Scientific and Medical Officer
David Strayer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$19.5M
Revenue (TTM)
$134.0K
Shares Outstanding
48.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.35
EPS
$-0.44
Book Value
$1.19
P/E Ratio
-0.9x
Price/Sales (TTM)
145.4
Price/Cash Flow (TTM)
---
Operating Margin
-16,278.36%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.